Floxuridine Injection, Powder, Lyophilized, For Solution
Product Images NDC 81643-9270
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Floxuridine (NDC 81643-9270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Jnd Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Floxuridine Cerona (Floxuridine For Injection Usp 2)
This is a prescription-only medication for intra-arterial use. The usual dosage should be determined by the package insert. It is a powder for reconstitution of floxuridine. The reconstituted solution should be stored at 2° to 8°C for not longer than 2 weeks. The medication is distributed by Cerona Therapeutics and is contained in a 5 mL vial. The medication should be stored between 20° to 25°C before being reconstituted for use.*
Representative Carton Serialization Image (Floxuridine For Injection Usp 3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.